The sponsor and global coordinator, acting on behalf of the international underwriters, fully exercised the over-allotment option as described in the prospectus on February 4, 2026. This action involved a total of 5.6129 million H shares, representing approximately 15% of the total shares available under the global offering prior to any exercise of the over-allotment option. The over-allotted shares will be issued and allotted by the Company at an H share price of HKD 116.20 per share. These shares are intended to facilitate the delivery of the relevant H shares to placees who agreed to postpone the delivery of their subscribed H shares under the global offering. Furthermore, the stabilization period related to the global offering concluded on February 4, 2026, which was the 30th day after the deadline for submitting applications under the Hong Kong public offering.
Comments